Pharmacy Syringe Purchase Test of Nonprescription Syringe Sales in San Francisco and Los Angeles in 2010
- 218 Downloads
The two main legal sources of clean needles for illicit injection drug users (IDUs) in California are syringe exchange programs (SEPs) and nonprescription syringe sales (NPSS) at pharmacies. In 2004, California became one of the last states to allow NPSS. To evaluate the implementation of NPSS and the California Disease Prevention Demonstration Project (DPDP), we conducted syringe purchase tests in San Francisco (SF) and Los Angeles (LA) between March and July of 2010. Large differences in implementation were observed in the two cities. In LA, less than one-quarter of the enrolled pharmacies sold syringes to our research assistant (RA), and none sold a single syringe. The rate of successful purchase in LA is the lowest reported in any syringe purchase test. In both sites, there was notable variation among the gauge size available, and price and quantity of syringes required for a purchase. None of the DPDP pharmacies in LA or SF provided the requisite health information. The findings suggest that more outreach needs to be conducted with pharmacists and pharmacy staff. The pharmacies' failure to disseminate the educational materials may result in missed opportunities to provide needed harm reduction information to IDUs. The varied prices and required quantities may serve as a barrier to syringe access among IDUs. Future research needs to examine reasons why pharmacies do not provide the mandated information, whether the omission of disposal options is indicative of pharmacies' reluctance to serve as disposal sites, and if the dual opt-in approach of NPSS/DPDP is a barrier to pharmacy enrollment.
KeywordsNonprescription syringe sales IDU SB1159 California Pharmacy Policy
We would like to thank Michèle Thorsen for her research assistance in San Francisco, and Patricia Case for sharing the syringe purchase protocol.
This study was supported by the National Institute on Drug Abuse grant number 1R21DA024966-01A1.
- 1.Injection drug users and their sex/needle sharing partners. Sacramento: Office of AIDS, California Department of Public Health; September 2007.Google Scholar
- 2.Alter MJ, Margolis HS, Bell BP, et al. Recommendations for the prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998; 47(RR19): 1–36.Google Scholar
- 3.Rodgers AB, Jones S, Abdul-Quader A, et al. New attitudes and strategies: a comprehensive approach to preventing blood-borne infections among IDUs. Atlanta, GA: Centers for Disease Control and Prevention; 2000.Google Scholar
- 4.Gayle HD, O'Neill JF, Gust SW, Mata A. HIV Prevention bulletin: medical advice for persons who inject illicit drugs. Atlanta, GA: US Department of Health and Human Services; 1997.Google Scholar
- 16.Farley TA, Niccolai LM, Billeter M, Kissinger PJ, Grace M. Attitudes and practices of pharmacy managers regarding needle sales to injection drug users. J Am Pharm Assoc (Wash). 1999; 39(1): 23–26.Google Scholar
- 17.Blumenthal W, Springer K, Jones S, Stark C. Pharmacy student knowledge, attitudes and beliefs about selling syringes to injection drug users. J Am Pharm Assoc. 2002; 42(6): S34–S39.Google Scholar
- 23.Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002). J Am Pharm Assoc. 2002; 42(Supplement 1): S83–S87.Google Scholar